Unrecognized Tax Benefits of aTYR PHARMA INC from 31 Dec 2012 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
aTYR PHARMA INC quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Dec 2012 to 31 Dec 2025.
  • aTYR PHARMA INC Unrecognized Tax Benefits for the quarter ending 31 Dec 2025 was $42,811,000, a 16% increase year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

aTYR PHARMA INC Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $42,811,000 +$6,054,000 +16% 31 Dec 2025 10-K 05 Mar 2026 2025 FY
Q4 2024 $36,757,000 +$6,679,000 +22% 31 Dec 2024 10-K 05 Mar 2026 2025 FY
Q4 2023 $30,078,000 +$4,933,000 +20% 31 Dec 2023 10-K 05 Mar 2026 2025 FY
Q4 2022 $25,145,000 +$2,913,000 +13% 31 Dec 2022 10-K 05 Mar 2026 2025 FY
Q4 2021 $22,232,000 +$525,000 +2.4% 31 Dec 2021 10-K 13 Mar 2025 2024 FY
Q4 2020 $21,707,000 +$405,000 +1.9% 31 Dec 2020 10-K 14 Mar 2024 2023 FY
Q4 2019 $21,302,000 +$1,659,000 +8.4% 31 Dec 2019 10-K 14 Mar 2023 2022 FY
Q4 2018 $19,643,000 +$3,085,000 +19% 31 Dec 2018 10-K 15 Mar 2022 2021 FY
Q4 2017 $16,558,000 +$3,558,000 +27% 31 Dec 2017 10-K 24 Mar 2021 2020 FY
Q4 2016 $13,000,000 +$7,967,000 +158% 31 Dec 2016 10-K 26 Mar 2020 2019 FY
Q4 2015 $5,033,000 +$3,927,000 +355% 31 Dec 2015 10-K 26 Mar 2019 2018 FY
Q4 2014 $1,106,000 +$159,000 +17% 31 Dec 2014 10-K 20 Mar 2018 2017 FY
Q4 2013 $947,000 +$173,000 +22% 31 Dec 2013 10-K 16 Mar 2017 2016 FY
Q4 2012 $774,000 31 Dec 2012 10-K 30 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.